Introduction
Autophagic degradation of mitochondria, or mitophagy, has been widely studied as an important process for mitochondrial quality control (see review ()). Intriguingly, recent studies reveal that mitochondrial clearance relies on extracellular vesicles (EVs) in the absence of the mATG8-conjugation system () or functional lysosomes (), indicating the emerging role of secretory autophagy in organelle secretion. Moreover, mitochondria can be packed into newly identified types of EVs, such as cardiac exophers during heterophagy for damaged mitochondria release from cardiomyocytes (; ), mitosomes (specialized migrasomes) during mitocytosis for damaged mitochondria release from migrating cells (), and mitophers during mitopherogenesis for healthy mitochondria release from worm spermatids (). Mitochondria-containing EVs (hereinafter referred as to Mito-EVs) can later be internalized by macrophages for elimination (; ) or stimulate innate immune response in other recipient cells ().
In this opinion piece, we compare the molecular mechanisms underlying the formation of five types of recently reported Mito-EVs and discuss the potential roles of secretory autophagy in releasing both damaged and healthy mitochondria.
Mitochondria release via extracellular vesicles
Mitochondria have been reported to transfer across cells through tunneling nanotubes, within extracellular vesicles, or in a carrier-free manner (see review ()). In the past two decades, mitochondrial-derived vesicles (MDVs) containing mitochondrial components and Mito-EVs containing fragmented or intact mitochondria have been observed in many cell types like mesenchymal stem cells (; ), endothelial cells (), platelets (), and iPSC-derived cardiomyocytes (). MDVs and Mito-EVs are formed under physiological and pathological conditions and may exert therapeutic effects in various diseases (see review (; )). Here, we compare five recently reported processes that produce Mito-EVs (Table 1) in depths.
TABLE 1
| Research | |||||
|---|---|---|---|---|---|
| Process name | Exophergenesis; Heterophagy | Autophagic secretion of mitochondria (ASM) | / | Mitocytosis | Mitopherogenesis |
| Mito-EV name | Exophers | / | / | Mitosomes (migrasomes) | Mitophers |
| EV size | 3.5 ± 0.1 μm in diameter by imaging | Larger than 0.22 μm (filtration cut-off) | Large EVs 115–550 nm in diameter by nanoparticle tracking | Up to 3 μm in diameter (embedded Mito 240 nm) by imaging | 720 nm in diameter (embedded Mito 600 nm) by imaging |
| EV markers | Externalized phosphatidylserine; LC3B | Not in CD63+ or CD9+ EVs | CD81, ALIX, TSG101, LC3A/B, and p62; Not in CD63+ EVs | TSPAN4; WGA staining | Externalized phosphatidylserine |
| Mito status | Damaged (aberrant morphology, loss of ΔΨm, and ↓citrate synthase activity) | Damaged (↑Ser65 p-Ub) | Intact | Damaged (aberrant morphology, loss of ΔΨm, and ↑ROS) | Healthy (normal morphology and normal ΔΨm) |
| Donor cell type | Cardiomyocytes | HeLa | MEFs; Cardiomyocytes and cardiac tissues | Cancer cells (L929 and MiaCaPa-2), normal cells (NRK and HUVEC), macrophages (BMDM and peritoneal), and neutrophils | C. elegans spermatids |
| Recipient cell type | Cardiac-resident macrophages (cMacs) | HeLa | Raw 264.7 macrophages and cMacs | / | / |
| Function or consequences | Maintain mitochondrial homeostasis in the heart; Prevent inflammasome activation and autophagic block | Maintain mitochondrial homeostasis in cells without mATG8- conjugation and activate cGAS- STING pathway in recipient cells | Maintain mitochondrial homeostasis in cells with defective lysosome and prevent inflammasome activation | Maintain mitochondrial homeostasis in migrating cells | Control quantity of mitochondria and maintain sperm motility and fertility |
| Activators | ↑ Autophagy: rapamycin | ↓ mATG8 lipidation: ATG7 Δ, ATG3 Δ, ATG5 Δ | ↓ Lysosomal function: bafilomycin A1, chloroquine; RAB7A Δ, T22N mutation; LAMP2 Δ, | ↑ Mito stress: Low dose of CCCP, DFP, antimycin A, and oligomycin | ↑ Extracellular protease: SWM-1 (protease inhibitor) Δ, pronase |
| ↓ cMacs: short- term Δ | AND ↑ Mito stress: antimycin A / oligomycin, and exhaustive exercise | Danon Disease mutations; aging (heart) | ↓ Serum: serum starvation | ↑ Mito outward translocation: SPE- 15 (myosin VI) Δ or inhibitor 2,4,6- triiodophenol | |
| ↑ Cardiac stress: isoproterenol | (RAB7A Δ increases basal but not damage- induced ASM) | ↓ ΔΨm: FCCP | ↑ Mito translocation: dynein Δ | ↑ Actin polymerization: phalloidin | |
| Inhibitors | ↓ Autophagy: ATG7 Δ in donor cells | ↓ Autophagosome biogenesis: ATG9 Δ; FIP200 Δ, | ↓ EV release: GW4869 | ↓ Mito translocation: KIF5B Δ, Myo19 Δ | ↓ Extracellular protease signaling: TRY-5 (protease) Δ, SPE-12 |
| ↓ cMacs: long-term Δ | ULK1/2 inhibitor SBI-0206965; | ↓ MVB-PM fusion: RAB27A Δ | ↓ Mito fission: Drp1 Δ | (transmembrane protein) Δ, SPE-8 (tyrosine kinase) Δ | |
| ATG14 Δ, class III PI3K inhibitor SAR405 | ↓ Migrasome formation: TSPAN9 Δ, and myosin II inhibitor blebbistatin | ↓ Actin polymerization: latrunculin A, CK- 636 | |||
| ↓ Autophagosome- PM fusion: SNAP23 Δ | |||||
| The mechanisms of Mito-EV formation | Not determined | PINK1-Pakin and NDP52 mediate mitophagosome formation without mATG8 lipidation. SNAP23 mediates mitophagosome fusion to PM. Secreted Mito is likely non- enveloped | When lysosomal function is impaired, Mitos are sequestered in CD81+vesicles. RAB27A mediates Mito- EV secretion, likely through MVB-PM docking/fusion | Microtubule motor KIF5B and actin motor Myo19 mediate damaged Mito translocation to PM. Drp1 mediates Mito fission. The Mito fragments on retraction fibers move into migrasomes | One healthy Mito is exported to PM on actin filaments. Extracellular protease, SPE-12, and SPE-8 mediate the signaling. Mitopher is formed by PM budding |
| Autophagy proteins involved (donor cells) | LC3B, ATG7 | ATG9A, ULK1 complex, and PI3KC3-C1 complex | Independent of mATG8 lipidation | Not tested | Not tested |
| Independent of mATG8 lipidation | LC3A/B, p62 may also secrete in CD81+ EVs | ||||
| Lysosomal proteins involved | Recipient cells: LAMP1 (Mito-LAMP1 colocalization) | Donor cells: Independent of lysosomal degradation (↓Mito-LAMP2 colocalization; bafilomycin A1 insensitive) | Donor cells: LAMP2 | Not tested | Not tested |
| Recipient cells: lysosomal degradation after uptake | |||||
| Relationship with mitophagy | Not determined | ASM is independent of mATG8 lipidation and autophagosome- lysosome fusion, while dependent on secretory autophagy | High doses of mitophagy- inducer FCCP induce Mito-EV secretion, which is independent of functional mitophagy (ATG5, ATG7, PINK1) | Low doses of CCCP induce mitocytosis, while high doses of CCCP induce mitophagy | Mitophagy may not occur as spermatids lack lysosomes |
Comparison of five recently reported processes that produce Mito-EVs.
Mito, mitochondria; EV, extracellular vesicle; ΔΨm, mitochondrial membrane potential; PM, plasma membrane; MVB, multivesicular body; ↑, increase; ↓, decrease; Δ, knockdown or knockout.
Mito-EVs vary in size and markers. Cardiac exophers are the largest, ranging from 3.5 ± 0.1 μm in diameter, positive for the “eat-me” signal externalized phosphatidylserine, and the autophagosomal marker LC3 (), while lysosomal impairment-induced Mito-EVs are the smallest, ranging from 115 to 550 nm in diameter, positive for multivesicular body (MVB) and EV markers CD81, ALIX, and TSG101 but not CD63, as well as autophagosomal markers LC3 and SQSTM1/p62 (). Mitosomes contain multiple small mitochondria of 240 nm size on average, positive for the migrasomal marker TSPAN4 (). During the autophagic secretion of mitochondria (ASM), the secreted mitochondria are bigger than 0.22 μm, negative for the EV markers CD63 and CD9 (). The mitochondria in the abovementioned processes are mostly damaged, assessed by morphology, mitochondrial membrane potential (ΔΨm), or other markers (; ; ). In contrast, mitophers are 720 nm in diameter, positive for externalized phosphatidylserine, embedding a single healthy mitochondrion of 600 nm size on average with normal morphology and ΔΨm ().
Mito-EVs function in the damaged mitochondria quality control or healthy mitochondria quantity control. Cardiac exophers and lysosomal impairment-induced CD81-positive Mito-EVs can be secreted from cardiomyocytes and taken up by macrophages in the neighborhood for degradation to prevent inflammation (; ), a process called heterophagy (). Cardiac-resident macrophages (cMacs) play an important role in maintaining mitochondrial homeostasis in the heart: short-term depletion of cMacs results in an accumulation of cardiac exophers, while the long-term depletion of cMacs reduces the formation of cardiac exophers through inflammasome activation and autophagy block in cardiomyocytes (). ASM takes place upon both mATG8-lipidation deficiency and mitochondrial stress in donor cells and stimulates cGAS–STING-mediated innate immune response in recipient cells of the same type (). Mitosomes are a kind of migrasomes, released by various migrating cells upon low doses of mitochondrial stressors (). Mitophers bud off C. elegans spermatids to reduce around 1/3 quantity of mitochondria to maintain sperm motility and fertility (). It is not clear how mitosomes and mitophers are ultimately cleared; we speculate that they can be internalized by other cells, for elimination or for material and/or signal transfer, since several kinds of migrasomes have been implicated to regulate lateral transfer of cellular contents (; ) and worm exophers produced from body wall muscles, a small population of which contains intact mitochondria and can transport yolk proteins to oocytes ().
The molecular mechanisms underlying the formation of Mito-EVs are characterized at different stages, including upstream signaling transduction, mitochondria translocation, cargo recognition, vesicle fusion, or budding. Mitophers are triggered by a signaling cascade consisting of extracellular protease TRY-5, transmembrane protein SPE-12, and tyrosine kinase SPE-8 (). Microtubules, actin cytoskeleton, and motor proteins play a vital role in mitochondria translocation. Actin polymerization is required and is sufficient to promote mitopher formation. Myosin VI SPE-15 negatively regulates mitochondrial outward transport on actin filaments (). During mitocytosis, the microtubule outward motor KIF5B and the actin motor Myo19 facilitate the transport of tubular mitochondria to the bottom of the cells to form mitosomes, while microtubule inward motor dynein inhibits the process; the tips of tubular mitochondria undergo Drp1-mediated fission before the mitochondrial fragments on the retraction fibers are packed into migrasomes, whose formation requires cell migration and tetraspanin proteins (). Autophagy proteins exhibit complex functions in cargo recognition and vesicle formation during cardiac exophergenesis, ASM, and lysosomal impairment-induced mitochondrial secretion, which are discussed in details in the later section. To release Mito-EVs, RAB27A mediates the docking and fusion of MVB to the plasma membrane (), whereas SNAP23 mediates the fusion of mitophagosome to the plasma membrane, and the authors suggest that the secreted mitochondria are non-enveloped during ASM (). Mitophers are released by direct budding from the plasma membrane, although the molecular mechanism remains elusive (). It is not examined how cardiac exophers get released (). Since cardiac exophers contain mitophagosomes, a fusion step between MVB or amphisomes to the plasma membrane may occur.
Roles of autophagic and lysosomal pathways on Mito-EVs
Mito-EVs show different dependencies on the autophagic pathway. Cardiac exophers, positive for LC3, require the mATG8-conjugation system as ATG7 knockdown in cardiomyocytes reduces the number of cardiac exophers, and autophagy induction by rapamycin is sufficient to induce cardiac exopher production (). The mATG8-conjugation system is dispensable for lysosomal impairment-induced CD81-positive Mito-EV secretion since ATG5 or ATG7 knockdown shows no effect; interestingly, LC3 and p62 are secreted in CD81-positive EVs upon the same treatment (), suggesting that Mito-EVs may carry such cargos as ubiquitinated proteins, and LC3/p62-dependent and independent EV cargo sorting pathways may co-exist. Consistent with this thought, LIR-containing RNA-binding proteins have been reported to secrete in LC3-positive EVs through a process named LC3-dependent EV loading and secretion (LDELS) (). When the mATG8-conjugation system is defective (ATG3-, ATG5-, and ATG7-knockout), PINK1–Parkin and the mitophagy cargo receptor NDP52 mediate the sorting of damaged mitochondria; upstream ATG proteins such as ATG9A, ULK1 complex, and PI3KC3-C1 complex control the formation of mitophagosomes, which later fuse with the plasma membrane instead of lysosomes (). These results indicate an inhibitory role of mATG8-conjugation machinery and a positive role of upstream ATG proteins on secretory autophagy. Notably, not all studies have evaluated ATG proteins upstream of mATG8 conjugation, and it remains elusive whether ATG proteins mediating autophagosome initiation and elongation regulate the formation of CD81-positive Mito-EVs, mitosomes, and mitophers, although the authors claim they are autophagy-independent.
Mito-EV formation barely needs lysosomal function. Worm spermatids that generate mitophers lack lysosomes (). When lysosomal function is compromised by pharmacological inhibitors (bafilomycin A1 and chloroquine), RAB7A depletion or dysregulation (inactive mutation T22N), LAMP2 depletion or Danon disease-causing mutations, or aging, CD81-positive Mito-EVs take charge to remove mitochondria (). Pharmacological inhibition of lysosomes does not affect ASM, and the colocalization of mitochondria and LAMP2 is reduced during ASM (). It is worth noting that after Mito-EVs are captured by recipient cells, especially macrophages, the clearance of Mito-EVs still involves lysosomal degradation (; ). This suggests that when mitophagy cannot occur in donor cells, Mito-EV secretion and heterophagy in recipient cells are compensatory processes.
Dual roles of secretory autophagy
In the past decade, an accumulating body of evidence has uncovered the role of secretory autophagy in conventional and unconventional secretions of a wide range of cargos for cellular homeostasis or intercellular communications (; ). However, the definition of secretory autophagy is still vague. For a cargo secretion process to be considered secretory autophagy, how many autophagy proteins, which may function at different stages of the autophagic pathway, shall be required? Shall autophagy proteins be on or in the cargo carriers? Shall autophagy proteins be sufficient to promote cargo secretion upon activation? It is urgent for the field to reach a consensus. Furthermore, the relationship between degradative and secretory autophagy needs in-depth investigation. It is intuitive to assume that the divergence point of degradative and secretory autophagy is the fusion step of autophagosomes. When autophagosome fuses with lysosome, cargos undergo degradative autophagy; when autophagosome fuses with late endosome, MVB, and/or the plasma membrane, cargos undergo secretory autophagy. However, as discussed above, neither ASM () nor lysosomal impairment-induced CD81-positive Mito-EV secretion () requires the mATG8-conjugation system, suggesting that the divergence point of degradative and secretory autophagy is rather upstream, likely the formation step of autophagosomes.
Mitochondria are well-known cargos of degradative autophagy (see review ()), and they could be cargos of secretory autophagy as well (Table 1). The secretion of cardiac exophers sets a good example of secretory autophagy because (1) autophagy is necessary for the Mito-EV secretion (ATG7-dependent); (2) autophagy protein is on the Mito-EV (LC3-positive); and (3) autophagy is sufficient for the Mito-EV secretion (rapamycin-induced). ASM shares the first two features with the secretion of cardiac exophers, the necessity of autophagy (ATG9A, ULK1 complex, and PI3KC3-C1 complex-dependent) and the presence of autophagy protein in the carriers (NDP52-positive), while the sufficiency of autophagy has not been tested. We propose that the following steps are involved in the secretory autophagy of mitochondria, applicable to different types of Mito-EVs: cargo sorting via autophagy receptor-cargo recognition, autophagosome formation, and the plasma membrane fusion or budding (Figure 1). Future studies shall evaluate more ATG proteins than the mATG8-conjugation system to determine whether secretory autophagy occurs.
FIGURE 1
In addition, we propose that both damaged and healthy mitochondria could be the cargos of secretory autophagy (Figure 1, “waste” vs. “food”): different cargos are sorted via distinct receptor–cargo pairs and packed into mitophagosomes. EVs that contain healthy mitochondria can be transferred from bone marrow-derived stromal cells to alveolar epithelial cells in injured lungs, restoring bioenergetics and improving survival (
In summary, Mito-EVs are novel structures that cells generate for mitochondrial quality or quantity control, some of which rely on secretory autophagy. Future research on autophagy proteins and Mito-EVs will not only shed light on the role of secretory autophagy in mitochondrial homeostasis but also on the mechanistic distinctions between degradative and secretory autophagy.
Statements
Author contributions
YG: writing–original draft. YZu: writing–original draft. LF: writing–original draft. YZo: writing–original draft and writing–review and editing.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China (32270804), Northwest A&F University Start-up Funding (2190021004), and Shaanxi Province Undergraduate Training Programs for Innovation and Entrepreneurship (S202310712442).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
BorcherdingN.BrestoffJ. R. (2023). The power and potential of mitochondria transfer. Nature623, 283–291. 10.1038/s41586-023-06537-z
2
BoudreauL. H.DuchezA. C.CloutierN.SouletD.MartinN.BollingerJ.et al (2014). Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood124, 2173–2183. 10.1182/blood-2014-05-573543
3
Hazan Ben-MenachemR.PinesO.SaadaA. (2024). Mitochondrial derived vesicles- quo vadis?FEBS J.10.1111/febs.17103
4
IkedaG.SantosoM. R.TadaY.LiA. M.VaskovaE.JungJ. H.et al (2021). Mitochondria-rich extracellular vesicles from autologous stem cell-derived cardiomyocytes restore energetics of ischemic myocardium. J. Am. Coll. Cardiol.77, 1073–1088. 10.1016/j.jacc.2020.12.060
5
IslamM. N.DasS. R.EminM. T.WeiM.SunL.WestphalenK.et al (2012). Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat. Med.18, 759–765. 10.1038/nm.2736
6
JiaoH.JiangD.HuX.DuW.JiL.YangY.et al (2021). Mitocytosis, a migrasome-mediated mitochondrial quality-control process. Cell184, 2896–2910.e13. 10.1016/j.cell.2021.04.027
7
LeidalA. M.HuangH. H.MarshT.SolvikT.ZhangD.YeJ.et al (2020). The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nat. Cell Biol.22, 187–199. 10.1038/s41556-019-0450-y
8
LiangW.SagarS.RavindranR.NajorR. H.QuilesJ. M.ChiL.et al (2023). Mitochondria are secreted in extracellular vesicles when lysosomal function is impaired. Nat. Commun.14, 5031. 10.1038/s41467-023-40680-5
9
LiuP.ShiJ.ShengD.LuW.GuoJ.GaoL.et al (2023). Mitopherogenesis, a form of mitochondria-specific ectocytosis, regulates sperm mitochondrial quantity and fertility. Nat. Cell Biol.25, 1625–1636. 10.1038/s41556-023-01264-z
10
Nicolas-AvilaJ. A.Lechuga-ViecoA. V.Esteban-MartinezL.Sanchez-DiazM.Diaz-GarciaE.SantiagoD. J.et al (2020). A network of macrophages supports mitochondrial homeostasis in the heart. Cell183, 94–109. 10.1016/j.cell.2020.08.031
11
Nicolas-AvilaJ. A.Pena-CousoL.Munoz-CanovesP.HidalgoA. (2022). Macrophages, metabolism and heterophagy in the heart. Circ. Res.130, 418–431. 10.1161/CIRCRESAHA.121.319812
12
PiccaA.FaitgJ.AuwerxJ.FerrucciL.D'amicoD. (2023). Mitophagy in human health, ageing and disease. Nat. Metab.5, 2047–2061. 10.1038/s42255-023-00930-8
13
PileticK.AlsalehG.SimonA. K. (2023). Autophagy orchestrates the crosstalk between cells and organs. EMBO Rep.24, e57289. 10.15252/embr.202357289
14
PonpuakM.MandellM. A.KimuraT.ChauhanS.CleyratC.DereticV. (2015). Secretory autophagy. Curr. Opin. Cell Biol.35, 106–116. 10.1016/j.ceb.2015.04.016
15
SpeesJ. L.OlsonS. D.WhitneyM. J.ProckopD. J. (2006). Mitochondrial transfer between cells can rescue aerobic respiration. Proc. Natl. Acad. Sci. U. S. A.103, 1283–1288. 10.1073/pnas.0510511103
16
TanH. W. S.LuG.DongH.ChoY. L.NataliaA.WangL.et al (2022). A degradative to secretory autophagy switch mediates mitochondria clearance in the absence of the mATG8-conjugation machinery. Nat. Commun.13, 3720. 10.1038/s41467-022-31213-7
17
TramontanoA. F.LyubarovaR.TsiakosJ.PalaiaT.DeleonJ. R.RagoliaL. (2010). Circulating endothelial microparticles in diabetes mellitus. Mediat. Inflamm.2010, 250476. 10.1155/2010/250476
18
TurekM.BanasiakK.PiechotaM.ShanmugamN.MaciasM.SliwinskaM. A.et al (2021). Muscle-derived exophers promote reproductive fitness. EMBO Rep.22, e52071. 10.15252/embr.202052071
19
YuS.YuL. (2022). Migrasome biogenesis and functions. FEBS J.289, 7246–7254. 10.1111/febs.16183
20
ZhangX.YaoL.MengY.LiB.YangY.GaoF. (2023). Migrasome: a new functional extracellular vesicle. Cell Death Discov.9, 381. 10.1038/s41420-023-01673-x
21
ZhouX.LiuS.LuY.WanM.ChengJ.LiuJ. (2023). MitoEVs: a new player in multiple disease pathology and treatment. J. Extracell. Vesicles12, e12320. 10.1002/jev2.12320
Summary
Keywords
mitochondria, secretory autophagy, extracellular vesicles, mitophagosome, membrane fusion, mitophagy, autophagosome formation
Citation
Gong Y, Zhou Y, Feng L and Zhao Y (2024) The roles of secretory autophagy in mitochondria release via extracellular vesicles: waste disposal and food delivery?. Front. Cell Dev. Biol. 12:1392810. doi: 10.3389/fcell.2024.1392810
Received
28 February 2024
Accepted
16 April 2024
Published
24 May 2024
Volume
12 - 2024
Edited by
Lorena Urbanelli, University of Perugia, Italy
Reviewed by
Chiara Ciardiello, G. Pascale National Cancer Institute Foundation (IRCCS), Italy
Updates

Check for updates
Copyright
© 2024 Gong, Zhou, Feng and Zhao.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yuting Zhao, yuting_zhao@nwafu.edu.cn
† These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.